Stockscreener 앱 받기
27.50
2.90%
-0.82
시간 외 거래:
27.54
0.04
+0.15%
Surmodics Inc 주식(SRDX)의 최신 뉴스
Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations - BioSpace
Can Surmodics Inc. stock reach $100 price targetSwing Trade & Real-Time Market Sentiment Reports - newser.com
Surmodics reports high success rate for Pounce thrombectomy device By Investing.com - Investing.com Canada
Will earnings trigger a reversal in Surmodics Inc.2025 Technical Overview & Low Drawdown Trading Strategies - newser.com
Surmodics (SRDX) Releases Positive Results from PROWL Registry S - GuruFocus
Surmodics reports high success rate for Pounce thrombectomy device - Investing.com
Surmodics shares data from 160 patients in PROWL registry using Pounce for real-world limb ischemia - MarketScreener
Published on: 2025-11-04 05:20:51 - newser.com
Surmodics (NASDAQ: SRDX) PROWL Registry Shows 0.6% Device-Related MAEs, 94.8% Flow Restoration - Stock Titan
Key metrics from Surmodics Inc.’s quarterly dataPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
Should you wait for a breakout in Surmodics Inc.2025 Bull vs Bear & Safe Capital Growth Tips - newser.com
Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3 - BioSpace
Discipline and Rules-Based Execution in SRDX Response - news.stocktradersdaily.com
Surmodics to present updated data on Pounce thrombectomy system By Investing.com - Investing.com Nigeria
Surmodics spotlights unique arterial thrombotic study at VIVA25 - Traders Union
What earnings revisions data tells us about Surmodics Inc.Weekly Risk Summary & Community Verified Trade Signals - newser.com
Can Surmodics Inc. stock deliver sustainable ROE2025 Stock Rankings & Daily Momentum Trading Reports - newser.com
Is it time to cut losses on Surmodics Inc.Portfolio Update Report & Fast Momentum Stock Entry Tips - newser.com
Surmodics to present updated data on Pounce thrombectomy system - Investing.com
Y Intercept Hong Kong Ltd Buys Shares of 42,975 Surmodics, Inc. $SRDX - MarketBeat
Is Surmodics Inc. stock resilient to inflationWeekly Market Outlook & Accurate Entry/Exit Alerts - newser.com
Will Surmodics Inc. stock return to pre crisis levelsWeekly Stock Recap & AI Powered Trade Plan Recommendations - newser.com
How to interpret RSI for Surmodics Inc. stockJuly 2025 Action & Risk Managed Trade Strategies - newser.com
Is Surmodics Inc. stock a safe investment in uncertain markets2025 Stock Rankings & Free Real-Time Volume Trigger Notifications - newser.com
How institutional ownership impacts Surmodics Inc. stock2025 Valuation Update & Risk Controlled Stock Pick Alerts - newser.com
Published on: 2025-11-01 01:11:15 - newser.com
Is Surmodics Inc. stock entering bullish territoryJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
Published on: 2025-10-31 04:30:06 - newser.com
Published on: 2025-10-31 04:03:38 - newser.com
Regression analysis insights on Surmodics Inc. performanceJuly 2025 Summary & Reliable Volume Spike Alerts - newser.com
Surmodics (SRDX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform - BioSpace
Surmodics (SRDX) PROWL Study Highlights Success in Thrombectomy Procedures - GuruFocus
Surmodics, Inc. (NASDAQ:SRDX) Given Average Rating of "Hold" by Analysts - MarketBeat
0.47%
0.23%
자본화:
|
볼륨(24시간):